Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

SangStat initiates bioequivalence trials of its ciclosporin formulation

July 19, 1996

Teijin reports naphthalene derivatives with immunosuppresive activity

July 19, 1996

Immunosuppressants reported by DuPont Merck

July 19, 1996

American Home Products issued U.S. patent for 42-epi-rapamycin

July 19, 1996

Positive safety, efficacy profile of HMG-CoA reductase inhibitors in hyperlipidemia treatment

July 12, 1996

ICOS issued U.S. patent relating to ICAM-3

July 12, 1996

TCV-309: Potential agent for transplantation of ischemically injured kidney

July 12, 1996

GT32-B: a novel antibacterial/antitumor immunosuppresant

July 12, 1996

Sankyo reveals potential immunosupressants

July 12, 1996

Immunosuppressive and antiinflammatory agents from Italfarmaco

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...